Will intracameral cefuroxime become the new standard in endophthalmitis prevention?;Prophylaxe der postoperativen infektiösen endophthalmitis durch intrakamerale cefuroximgabe - Auf dem weg zum therapiestandard?

Klinische Monatsblatter fur Augenheilkunde

Volumn 225, Issue 11, 2008, Pages 934-940

  Pleyer, Uwe ^a,c   Geldsetzer, K ^b  

^a Charité Campus Virchow Klinik

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cataract; Endophthalmitis; Intraocular inflammation; Microbiology; Prevention; Risk factor

Indexed keywords

CEFUROXIME; LEVOFLOXACIN;

AQUEOUS HUMOR; ARTICLE; BACTERIUM ISOLATE; CATARACT EXTRACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOPHTHALMITIS; FACTORIAL DESIGN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; PHACOEMULSIFICATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; VISUAL IMPAIRMENT;

EID: 57449086164     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027148     Document Type: Article

References (12)

1. Seal DV, Barry P, Gettinby G et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: case for a European multicenter study. J Cataract Refract Surg 2006; 32: 396-406
2. Barry P, Behrens-Baumann W, Pleyer U et al. ESCRS Guidelines on prevention, investigation and management of post-operative endophthalmitis. Version 2 (August 2007). Dublin. Ireland: The European Society for Cataract & Refractive Surgeons
3. Taban M, Behrens A, Newcomb RL et al. Acute endophthalmitis following cataract surgery. Arch Ophthalmol 2005; 123: 613-620
4. Isenberg SJ, Apt L, Yoshimori R et al. Efficacy of topical povidone-iodine during the first week after ophthalmic surgery. Am J Ophthalmol 1997; 124: 31-35
5. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 2007; 33: 978-988
6. Seal DV, Reischl U, Behr A et al. Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European (ESCRS) multicenter study and susceptibility testing. J Cataract Refract Surg: eingereicht zur Publikation
7. Sundelin K, Stenevi U, Seal D et al. Enhanced anterior chamber penetration of topical levofloxacin 0.5%, with pulsed dosing. Acta Ophthalmol Scand: eingereicht zur Publikation
8. Montan P, Wejde G, Koranyi G et al. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002; 28: 977-981
9. Lundström M, Wejde G, Stenevi U et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007; 114: 866-870
10. Bucci FA. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol 2004; 137: 308-312
11. Colin J, Simonpoli S, Geldsetzer K et al. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand 2003; 81: 611-613
12. Koch HR, Kulus SC, Roessler M et al. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. J Cataract Refract Surg 2005; 31: 1377-1385